Trials / Withdrawn
WithdrawnNCT02625779
Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
A Double-Blind, Placebo-Controlled Trial of Combined Cytidine- and Creatine-containing Drug and Dietary Supplement in the Treatment of the Bipolar Depression
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ewha Womans University Mokdong Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This research is aimed to investigate the efficacy and safety of the creatine and cytidine augmentation in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using proton and phosphorous magnetic resonance spectroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valproate and Placebo | |
| DRUG | Valproate and Cytidine-containing Drug | |
| DRUG | Valproate and Creatine-containing Drug |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-04-30
- Completion
- 2017-04-30
- First posted
- 2015-12-09
- Last updated
- 2018-02-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02625779. Inclusion in this directory is not an endorsement.